Liquid Biopsy Myths Dispelled
Guardant360 is the only biopsy-free tumor sequencing test
that tracks tumor genomics in real-time.
These genomic alterations can aid with identifying treatment options,
all with a simple blood test.
Eliminates the risk and cost associated with tissue biopsies
A comprehensive panel of 68 clinically relevant genes that interrogates all active disease sites
Captures the constantly evolving adaptive response of the tumor at any point in time
“I’ve been very impressed with the ability of Guardant360 to provide rapid information on mutation status of over 50 genes as well as copy number information on several genes…This is information that I’ve used to change the management of metastatic colorectal cancer patients.”
Dr. Scott Kopetz
Associate Professor, GI Medical Oncology MD Anderson Cancer Center
“I’m very excited that the power of non-invasive tumor sequencing will soon be available to all cancer patients through Guardant360.”
Dr. Dave S. Hoon
Director, Molecular Oncology
John Wayne Cancer Institute